Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Typhoid intestinal perforation
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • Past Conferences
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

New trial investigates typhoid conjugate vaccine in Africa

Posted on February 28, 2018 by admin
  • The Typhoid Vaccine Acceleration Consortium, or TyVAC, recently launched a trial assessing the effectiveness and cost-effectiveness of the new typhoid conjugate vaccine, Typbar TCV®, among children in Malawi

Post navigation

Malawi is first African nation using new WHO approved typhoid vaccine
Increased Diagnoses of Typhoid Fever, Shigellosis Linked to SE Asia Visits

Newsletter Signup

Recent Posts

  • Teamwork to take on typhoid and win a World Cup

  • Un travail d’équipe pour relever le défi de la typhoïde et remporter une Coupe du monde

  • Stories of typhoid: Mothers in Kenya

  • Protecting the next generation: How typhoid conjugate vaccines changed the game

  • For every generation, vaccines work: The courage and commitment behind Kenya’s lifesaving immunization story

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2000 Pennsylvania Ave, NW, Suite 7000
Washington, DC 20006
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top